Delivering mitochondrial health
In mid-May, Abliva will attend and present at Bio€quity Europe 2023 in Dublin, Ireland. "For more than 20 years, Bio€quity Europe has been where CEOs and investors gather to network, partner and debate critical issues facing the biotech industry today." CEO Ellen Donnelly will present the company on May 15 during the session Other Approaches […]
On May 25, Abliva will participate at Erik Penser Bank's Penser Market Bolagsdag in Stockholm. Abliva's CMO, Magnus Hansson, will be presenting the company during the morning session. Further details and link to event below.
In late May, Abliva will attend and present at ABG Sundal Collier's Life Science Summit Seminar in Stockholm, Sweden. The event will also be live-streamed. See below for more info.
In early June, Abliva will attend the BIO International Convention in Boston, US.
In June, Abliva will attend this year's edition of Euromit - the international conference on mitochondrial disease. The meeting takes place in Bologna, Italy, and gathers researchers, clinicians, and patients for the sharing of knowledge and insights in the field. The conference also presents opportunities to meet with investigators in our FALCON study with KL1333.
In late June, Abliva will be attending this year's international Mitochondrial Medicine Symposium, organized by US patient organization United Mitochondrial Disease Foundation. The meeting will take place in Charlotte, North Carolina (US), on June 28 - July 1, and includes both scientific as well as patient and family sessions.
Abliva will participate at the 12th annual edition of 'The Future of Swedish & Danish Life Science', on September 7, 2023, in Lund, Sweden. The company's Chief Medical Officer, Magnus Hansson, will give a talk entitled Pivotal study design in a rare disease with no regulatory precedent – utilizing patient advocacy groups and registries. "The […]
In September, Abliva will attend the LSX World Congress USA, in Boston, MA. The event gathers North America’s leading Biotech, Medtech and Healthtech CEOs along with investors, big pharma, and advisors.
Our Chief Medical Officer, Magus Hansson, will give a talk at Penser South Company Day in Malmö, on September 14, 2023. Click the link below for more details and registration.
During World Mitochondrial Disease Week, Abliva's Chief Medical Officer, Magnus Hansson, will present the company at the Cure Mito Foundation's Empower & Inspire - 2nd Annual Leigh Syndrome Symposium (virtual). See below for more information and the link to the event.
In late October, Abliva will attend the BioStock's Life Science Summit at Medicon Village in Lund. Magnus Hansson, Abliva's Chief Medical Officer, will be presenting the company at 09:05 a.m. CET on October 25. See more details and the link to the event below.
In October, Abliva's CEO, Ellen Donnelly, will attend Hadean Venture's annual event in Oslo.
